The Valley Desk

NCT03452228 · Interventional trial

Safety and Efficacy Following Repeat-Dose of Evinacumab (Anti-ANGPTL3) in Patients With Severe Hypertriglyceridemia (sHTG) at Risk for Acute Pancreatitis

Overall registry status Completed

Phase 2

Conditions Severe Hypertriglyceridemia (sHTG)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov